EMA Excellence in Pharmacovigilance: Clinical Trials and Post-marketing Training, London, 18-22 February 2013
Jan 28, 2013
Dr Jan Petracek of PharmInvent will be lecturing at the 5-day training course presented by the European Medicines Agency and organised by DIA in London. This course is designed to provide a firm grounding in key aspects of Global Clinical Pre and Post Marketing Safety and includes highlights and updates on the implementation of the new pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance. Professionals involved in pharmacovigilance, clinical research, regulatory affairs, risk management, medical product safety assessment, and data analysis, epidemiology, labelling, quality assurance, compliance, medical information will be attending this training.